Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Enterprise Value for 2 consecutive years, with $6.8 million as the latest value for Q4 2024.
- Quarterly Enterprise Value fell 2.93% to $6.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2024, down 2.93% year-over-year, with the annual reading at $6.6 million for FY2024, 6.81% down from the prior year.
- Enterprise Value for Q4 2024 was $6.8 million at Zhengye Biotechnology Holding, down from $7.0 million in the prior quarter.
- The five-year high for Enterprise Value was $7.0 million in Q4 2023, with the low at $6.8 million in Q4 2024.